Clinical Trials

We have both prevention and symptomatic trials. Our current prevention trial is listed at the top, followed by our symptomatic trials.

Have you been diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer’s Disease (AD)? We are interested in testing if a combination therapy (AMX0035) can reduce neuroinflammation and neuronal death in patients with MCI or probable AD.